| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/07/2002 | US20020028915 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/07/2002 | US20020028851 Guanylhydrazones and their use to treat inflammatory conditions |
| 03/07/2002 | US20020028836 Potassium channel openers |
| 03/07/2002 | US20020028835 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 03/07/2002 | US20020028831 Phenylpyridine derivatives useful as phosphodiesterase inhibitors |
| 03/07/2002 | US20020028828 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | US20020028826 HMG-CoA reductase inhibitors and method |
| 03/07/2002 | US20020028821 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 03/07/2002 | US20020028817 Platelet derived growth factors (PDGF); 1,2-dimethyl-6-(2-thiophene)imidazolo(5,4-g)quinoxaline preparations for example; use treating proliferative malignant and non-malignant diseases; stents |
| 03/07/2002 | US20020028815 Novel multicyclic compounds and the use thereof |
| 03/07/2002 | US20020028812 Phenylalanine derivatives |
| 03/07/2002 | US20020028809 Heterocyclic compounds having effect of activating a4beta2 nicotinic acetylcholine receptors |
| 03/07/2002 | US20020028807 5,11-Dihydro-11-ethyl-5-methyl-8-(2-((1-oxido-4-quinolinyl) oxy)ethyl)-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one for example; inhibitor of HIV replication; treating or preventing HIV infection |
| 03/07/2002 | US20020028803 Controlling cell apoptosis |
| 03/07/2002 | US20020028799 Using protease and phospodiesterase inhibitor |
| 03/07/2002 | US20020028796 Adjustment mineral concentration |
| 03/07/2002 | US20020028790 Use of agonists or antagonists of P2 purinoceptors for the prevention glutamate-evoked cytotoxicity |
| 03/07/2002 | US20020028784 Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences |
| 03/07/2002 | US20020028777 Novel sulfofucosylacylglycerol derivatives and use thereof as medicaments |
| 03/07/2002 | US20020028776 Polymerase inhibitor; anticancer agent |
| 03/07/2002 | US20020028774 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/07/2002 | US20020028772 Modulation of metabolism |
| 03/07/2002 | US20020028766 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/07/2002 | US20020028760 Nervous system disorders; hypotensive agents; incontinence |
| 03/07/2002 | US20020028514 Recombinant AAV vector-based transduction system and use of same |
| 03/07/2002 | US20020028510 Cells for use in the treatment of nervous system disorders |
| 03/07/2002 | US20020028436 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 03/07/2002 | US20020028238 Orally administration to provide a blood plasma concentration profile of celecoxib of at least about 250 mg/ml in not more than about 30 minutes |
| 03/07/2002 | US20020028236 Erythropoietin or derivatives that cause bone marrow cells to increase production of reticulocytes and erythrocytes; hydrogenated lecithin that may be hydrogenated; cholesterol or a derivative; phosphate buffer |
| 03/07/2002 | US20020028227 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 03/07/2002 | US20020028203 T cell inhibitory receptor compositions and uses thereof |
| 03/07/2002 | US20020028199 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC) |
| 03/07/2002 | US20020028195 Viruses for the treatment of cellular proliferative disorders |
| 03/07/2002 | DE10042059A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 03/07/2002 | DE10042058A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 03/07/2002 | DE10041574A1 Chromenonderivate Chromenonderivate |
| 03/07/2002 | DE10041428A1 Biphenylderivate Biphenyl |
| 03/07/2002 | DE10041423A1 Biphenylderivate Biphenyl |
| 03/07/2002 | DE10038043A1 Phamakologisch wirksame Substanz zur Behandlung kardiovaskulärer Erkrankungen Of pharmacologically active substance for the treatment of cardiovascular diseases |
| 03/07/2002 | CA2746787A1 Method of increasing testosterone and related steroid concentrations in women |
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/07/2002 | CA2421893A1 Phosphate derivatives as immunoregulatory agents |
| 03/07/2002 | CA2421503A1 Methods and compositions for inhibiting angiogenesis |
| 03/07/2002 | CA2421055A1 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | CA2420969A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | CA2420869A1 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | CA2420867A1 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | CA2420856A1 Control of crop pests and animal parasites through direct neuronal uptake |
| 03/07/2002 | CA2420852A1 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 03/07/2002 | CA2420835A1 Composition and method for treatment of hypertriglyceridemia |
| 03/07/2002 | CA2420832A1 Methods and reagents for protease inhibition |
| 03/07/2002 | CA2420804A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | CA2420673A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 03/07/2002 | CA2420667A1 Quinoline-(c=o)-(di-,tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | CA2420591A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | CA2420569A1 Use of threo-methylphenidate compounds to enhance memory |
| 03/07/2002 | CA2420532A1 Pharmaceutical formulation of salmeterol and fluticasone propionate |
| 03/07/2002 | CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | CA2420286A1 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 03/07/2002 | CA2420178A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
| 03/07/2002 | CA2420103A1 Modulation of fas and fasl expression |
| 03/07/2002 | CA2419935A1 Collagen/polysaccharide bilayer matrix |
| 03/07/2002 | CA2419699A1 Gem-substituted .alpha. v .beta. 3 integrin antagonists |
| 03/07/2002 | CA2419623A1 Method for treatment of migraine using pde5 inhibitors |
| 03/07/2002 | CA2419606A1 Lung surfactant compositions with dynamic swelling behaviour |
| 03/07/2002 | CA2419399A1 Nucleoside derivatives for the treatment of hepatitis c |
| 03/07/2002 | CA2419255A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/07/2002 | CA2419152A1 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 03/07/2002 | CA2418041A1 Pyrrolidine derivatives and their use as chymase inhibitor |
| 03/06/2002 | EP1184465A2 Method for diagnosing polymorphisms in human MCT-1 and drugs related to such polymorphisms |
| 03/06/2002 | EP1184388A1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof |
| 03/06/2002 | EP1184384A1 1-(Alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7-pyridin-4-ylimidazo(1,2a)pyrimidin-5(1H)-one derivatives |
| 03/06/2002 | EP1184376A1 Novel heterocyclic carboxamide derivatives |
| 03/06/2002 | EP1184373A1 Tricyclic compounds |
| 03/06/2002 | EP1184372A1 Phenoxyphenylheterocycle derivatives as selective serotonin reuptake inhibitors (SSRIs) |
| 03/06/2002 | EP1184366A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha(ppar) |
| 03/06/2002 | EP1184037A1 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance |
| 03/06/2002 | EP1184036A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 03/06/2002 | EP1183534A2 Identification of novel mechanisms of drug resistance |
| 03/06/2002 | EP1183384A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 03/06/2002 | EP1183370A2 Human oxidoreductase proteins |
| 03/06/2002 | EP1183362A1 Il-1 eta dna and polypeptides |
| 03/06/2002 | EP1183359A2 Nucleic acids and proteins with interferon-beta activity |
| 03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 03/06/2002 | EP1183352A1 Vascular endothelial growth factor variants |
| 03/06/2002 | EP1183344A2 Adam polynucleotides and polypeptides |
| 03/06/2002 | EP1183329A2 Differentiated human embryoid cells and a method for producing them |
| 03/06/2002 | EP1183274A1 Method and compounds for inhibiting activity of serine elastases |
| 03/06/2002 | EP1183273A1 C-cam as an angiogenesis inhibitor |
| 03/06/2002 | EP1183269A1 Attenuated microorganisms for the treatment of infection |
| 03/06/2002 | EP1183256A1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 03/06/2002 | EP1183245A1 Selective npy (y5) antagonists |
| 03/06/2002 | EP1183241A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 03/06/2002 | EP1183240A1 Beta2-adrenoceptor agonists |
| 03/06/2002 | EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/06/2002 | EP1183237A1 Novel antioxidants, preparation methods and uses |
| 03/06/2002 | EP1183235A2 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183234A1 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP1183231A1 Cytofectin dimers and methods of use thereof |